Latest News and Press Releases

Austin, TX, USA, March 07, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Proton Therapy Market Size, Trends and Insights By Setup Type (Single-Room...

ALACHUA, Fla. and TAMPA, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...

Austin, TX, USA, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Medical Implant Market Size, Trends and Insights By Product Type (Orthopedic...

REPOSE® met its primary endpoint of non-inferiority between the pain visual analog scale outcomes for neurectomy with Axoguard Nerve Cap® vs. standard-of-care neurectomy at Month 12. Axoguard Nerve...

OPERA-01 pivotal Phase 3 monotherapy clinical trial on track, with clinical site activation ongoing and first patient expected to be enrolled in fourth quarterNew clinical data for palazestrant...

ALACHUA and TAMPA, Fla., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...

Austin, TX, USA, July 18, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Women’s Health Diagnostics Market Size, Trends and Insights By Application...

StemPrintER outperformed the current market leader, OncotypeDX test, in stratifying patients according to their risk of breast cancer recurrence LONDON and PHOENIX, July 11, 2023 (GLOBE NEWSWIRE)...

New York, July 05, 2023 (GLOBE NEWSWIRE) -- The global cancer biomarkers market is estimated to grow at a CAGR of ~14% from 2023 to 2033. The market is estimated to garner a revenue of nearly USD 33...

New York, USA, April 12, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research dive, the global cancer stem cells market is anticipated to garner $1,722.7 million in revenue and rise...